Fundraising Fox

Fibrocell Science

Exton, US · Delaware corporation

Biotech

Founders & leadership

DP
DAVID PERNOCKChairman of the Board and Chief Executive Officer
KA
KEITH A. GOLDANSenior Vice President, Chief Financial Officer and Treasurer
JM
JOHN MASLOWSKISenior Vice President, Scientific Affairs
MF
MICHAEL F. MARINOExecutive

Board

JK
JULIAN KIRKBoard director
DJ
DOUGLAS J. SWIRSKYBoard director
KM
KELVIN MOOREBoard director
MM
MARC MAZURBoard director
CS
CHRISTINE ST.CLAREBoard director
ME
MARCUS E. SMITHBoard director

Reported raises · per SEC filings

Form D private placements

$26.7M disclosed across 4 rounds · 2016–2018

▶$900KraisedDec 2018 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • DOUGLAS J. SWIRSKYDirector
  • SEAN D. BUCKLEYExecutive Officer
  • MARC B. MAZURDirector
  • MARCUS E. SMITHDirector
  • CHRISTINE ST.CLAREDirector
  • JOHN M. MASLOWSKIExecutive Officer, Director
  • KELVIN D. MOOREDirector
  • JULIAN P. KIRKDirector
Offering amount
$900K
Amount sold
$900K
First sale
Dec 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedJul 2018 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MARC B. MAZURDirector
  • MARCUS E. SMITHDirector
  • DOUGLAS J. SWIRSKYDirector
  • KELVIN D. MOOREDirector
  • JOHN M. MASLOWSKIExecutive Officer, Director
  • CHRISTINE ST.CLAREDirector
  • JULIAN P. KIRKDirector
Offering amount
$3.1M
Amount sold
$3.1M
Sales commissions
$8.4K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Jul 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.1MraisedJun 2018 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • DOUGLAS J. SWIRSKYDirector
  • CHRISTINE ST.CLAREDirector
  • JULIAN P. KIRKDirector
  • MARC B. MAZURDirector
  • JOHN M. MASLOWSKIExecutive Officer, Director
  • MARCUS E. SMITHDirector
  • KELVIN D. MOOREDirector
Offering amount
$5.1M
Amount sold
$5.1M
Sales commissions
$13.4K
Placement agents
H.C. Wainwright & Co., LLC
First sale
May 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.6MraisedAug 2016 · 14 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • DOUGLAS J. SWIRSKYDirector
  • JULIAN KIRKDirector
  • DAVID PERNOCKExecutive Officer, Director
  • KEITH A. GOLDANExecutive Officer
  • JOHN MASLOWSKIExecutive Officer
  • KELVIN MOOREDirector
  • MICHAEL F. MARINOExecutive Officer
  • MARC MAZURDirector
  • CHRISTINE ST.CLAREDirector
  • MARCUS E. SMITHDirector
Offering amount
$25M
Amount sold
$17.6M
First sale
Aug 2016
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Fibrocell Science raised?
Fibrocell Science has disclosed $26.7M raised across 4 rounds.
Where is Fibrocell Science headquartered?
Fibrocell Science is headquartered in Exton, US.